Beijing Bohui Innovation Biotechnology Group Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Zhiwei Shen
Chief executive officer
CN¥1.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.5yrs |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 3.5yrs |
Recent management updates
CEO
Zhiwei Shen (46 yo)
1.5yrs
Tenure
CN¥1,595,400
Compensation
Mr. Zhiwei Shen has been Chairman and Non-Independent Director at Beijing Bohui Innovation Biotechnology Group Co., Ltd. (formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd.) since June 01,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 1.5yrs | CN¥1.60m | no data | |
| Financial Director | 1.5yrs | CN¥536.00k | no data | |
| Deputy GM | 4.3yrs | CN¥834.70k | no data | |
| Accounting Supervisor | no data | no data | no data |
1.5yrs
Average Tenure
40yo
Average Age
Experienced Management: 300318's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 4.5yrs | CN¥1.60m | no data | |
| Deputy GM | 2.5yrs | CN¥834.70k | no data | |
| Chairman of the Supervisory Board | 10.6yrs | no data | 3% CN¥ 149.8m | |
| Independent Director | 4.5yrs | CN¥100.00k | no data | |
| Independent Director | 4.5yrs | CN¥100.00k | no data | |
| Employee Representative Supervisor | 4.5yrs | no data | 0.00034% CN¥ 17.0k | |
| Independent Director | 1.5yrs | CN¥50.40k | no data | |
| Non-Independent Director | 1.5yrs | no data | no data | |
| Non-Independent Director | 1.5yrs | CN¥1.40m | no data | |
| Non-Employee Supervisor | 1.5yrs | no data | no data |
3.5yrs
Average Tenure
55.5yo
Average Age
Experienced Board: 300318's board of directors are considered experienced (3.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 19:06 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Bohui Innovation Biotechnology Group Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yan Wen | TX Investment Consulting Co., Ltd. |